Yangping Wu

Tianjin, CN.

Work

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
|

Doctor of Philosophy (PhD) Candidate - Pediatric Hematology and Oncology Center

Tianjin, Heping District, China

→

Summary

Advanced biomedical research focused on T-cell pathogenesis & functionality and optimization of adoptive T-cell immunotherapies within a top-tier academic medical center.

Tongji Medical College, Huazhong University of Science & Technology
|

Bachelor of Clinical Medicine

Wuhan, Hubei, China

→

Summary

Completed clinical medical training while gaining early scientific research experience.

Skills

Cell Therapy
Flow Cytometry
Mouse Models
Cell Biology
Molecular Biology
Analytics
Data Analysis

Publications

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia

Published by

Blood

Summary

Dissected clonal evolution in T-ALL, identifying high MSI2 levels as a promoter of chemoresistance and offering new therapeutic insights.

Developing PROteolysis TArgeting Chimeras (PROTACs) for hematologic malignancies

Published by

Cancer Letters

Summary

Developed PROteolysis TArgeting Chimeras (PROTACs) as a novel therapeutic strategy for hematologic malignancies.

Languages

Chinese
English
German
French